Justice Sanjeev Sachdeva on Monday said the arbitral award of September 14, 2015 was plagued with patent illegalities and fraud and was also in conflict with the public policy of India.
The judge said that the Supreme Court, hearing a plea regarding fraudulent act of Devas in January said ‘the very seeds of the commercial relationship between Antrix and Devas were a product of fraud perpetrated by Devas and thus every part of the plant that grew out of those seeds, such as the agreement, the disputes, arbitral awards were all infected with the poison of fraud’.
The judge also said that the findings of the Supreme Court indicate the award was antithetical to the fundamental policy of Indian law, as it was contrary to the national economic interests and violated the Foreign Investment Promotion Board (FIPB) policies and Prevention of Money Laundering Act (PMLA).